Form 4: GE HealthCare Director Risa J. Lavizzo-Mourey Awarded Restricted Stock Units

GE HealthCare Technologies Inc. announced that Director Risa J. Lavizzo-Mourey was granted 3,092 restricted stock units as part of her compensation, aligning her interests with shareholders.

Summary

• Risa J. Lavizzo-Mourey, a Director at GE HealthCare Technologies Inc. (GEHC), was awarded 3,092 restricted stock units (RSUs) on May 28, 2025.
• Each restricted stock unit represents the right to receive one share of GE HealthCare common stock.
• The RSUs will vest 100% on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Following this transaction, Ms. Lavizzo-Mourey beneficially owns 10,157 shares of GE HealthCare common stock.
• Settlement of vested RSUs may be deferred by the reporting person in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects standard corporate governance practices and aligns director interests with shareholders, without indicating any negative operational or financial news.

Positives

• The award of restricted stock units to a director helps align their interests with those of the company's shareholders.
• This transaction represents a standard component of non-employee director compensation, indicating stable corporate governance practices.

Future Outlook

The restricted stock units granted to Director Risa J. Lavizzo-Mourey are scheduled to vest 100% on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026. Settlement of these vested units may be deferred by the reporting person.

Industry Context

The granting of restricted stock units to non-employee directors is a common practice across publicly traded companies, particularly in the healthcare technology sector, to attract and retain qualified board members and align their long-term interests with shareholder value.

Management Changes

Corporate Governance

Related Party Transactions

• The award of restricted stock units to Risa J. Lavizzo-Mourey, a director of GE HealthCare Technologies Inc., constitutes a transaction with a related party, which is a standard component of director compensation.

Stakeholder Impact

• Shareholders: The RSU award aligns the director's financial interests with long-term shareholder value.
• Director (Risa J. Lavizzo-Mourey): Increases her equity stake in the company, providing a direct financial incentive tied to company performance.

Next Steps

• Vesting of the 3,092 restricted stock units on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Potential settlement or deferral of the vested restricted stock units as per the company's Non-Employee Director Compensation and Benefits Plan.

Key Dates

Recommendation

Keywords

GE HealthCare Technologies Inc., GEHC, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, SEC Form 4, Equity Award, Corporate Governance